Elena Jiménez-Martí

Profresora Ayudante Doctor

University of Valencia

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Elena Jiménez-Martí is an Assistant Professor at the Universitat de València in Spain. Her research focuses on areas including atherosclerosis, gastric cancer, and immune profiling in various populations. Recent publications have highlighted differences in immune subgroup responses and the implications of educational interventions in cancer awareness. She also investigates the impact of diet on liver disease and the efficacy of therapeutic strategies against Helicobacter pylori infection.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

SPAIN

View details

Herminia Gonzalez-Navarro

Profesora Titular

University of Valencia

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Elena Jiménez-Martí

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Increased CX3CL1/CX3CR1 Axis Is Related to Atherosclerosis in Subjects with Familial Combined Hyperlipidaemia, Which Is Modulated by Insulin Resistance but Not by Sex

Comprehensive histopathological analysis of gastric cancer in European and Latin America populations reveals differences in PDL1, HER2, p53 and MUC6 expression

Immune profiling of gastric adenocarcinomas in EU and LATAM countries identifies global differences in immune subgroups and microbiome influence

Implementation of an Educational Intervention for Gastric Cancer Awareness in the General Population in CELAC and Europe: A Strategy Proposed by the LEGACy Consortium

Integrated clinico-molecular analysis of gastric cancer in European and Latin American populations: LEGACY project

Treatment with 1.25% cholesterol enriched diet produces severe fatty liver disease characterized by advanced fibrosis and inflammation and impaired autophagy in mice

Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in European and Latin American countries.

Light deficiency in Apoe-/-mice increases atheroma plaque size and vulnerability by modulating local immunity.

SAT-387 Characterisation of invariant natural killer T cells in human hepatic biopsies

WED-520 Light cytokine-deficiency effects in inmune cells subpopulations in a murine non alcohol-related steatohepatitis model

RUNAT-BI: A Ruthenium(III) Complex as a Selective Anti-Tumor Drug Candidate against Highly Aggressive Cancer Cell Lines

A novel adenine-based diruthenium(III) complex: Synthesis, crystal structure, electrochemical properties and evaluation of the anticancer activity

Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone Peptide-Derived G Protein Coupled Receptor Agonists

The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally

Collaborators (6)

Blanca Alabadí

Andrés Cervantes

Isabel Castro

Jose Manuel Mas

José Martínez-Lillo

Herminia Gonzalez-Navarro

Make your next move.